{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:30:17Z","timestamp":1778509817216,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005029","name":"Helse Vest Regionalt Helsef\u00f8retak","doi-asserted-by":"publisher","award":["912246"],"award-info":[{"award-number":["912246"]}],"id":[{"id":"10.13039\/501100005029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["NOR-OPENSCREEN 245922\/F50"],"award-info":[{"award-number":["NOR-OPENSCREEN 245922\/F50"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["261826"],"award-info":[{"award-number":["261826"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.biochi.2020.12.002","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T05:12:28Z","timestamp":1607577148000},"page":"126-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Levalbuterol lowers the feedback inhibition by dopamine and delays misfolding and aggregation in tyrosine hydroxylase"],"prefix":"10.1016","volume":"183","author":[{"given":"Marte I.","family":"Flydal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trond-Andr\u00e9","family":"Kr\u00e5kenes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Dayne S.","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria P.A.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Knut","family":"Teigen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1643-6506","authenticated-orcid":false,"given":"Aurora","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biochi.2020.12.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","article-title":"Tyrosine hydroxylase and regulation of dopamine synthesis","volume":"508","author":"Daubner","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biochi.2020.12.002_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sbi.2015.07.004","article-title":"Structural insights into the regulation of aromatic amino acid hydroxylation","volume":"35","author":"Fitzpatrick","year":"2015","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"6","key":"10.1016\/j.biochi.2020.12.002_bib3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C","article-title":"Cytotoxic and genotoxic potential of dopamine","volume":"55","author":"Stokes","year":"1999","journal-title":"J.\u00a0Neurosci. Res."},{"issue":"6","key":"10.1016\/j.biochi.2020.12.002_bib4","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/jnc.14675","article-title":"Tyrosine hydroxylase phosphorylation in\u00a0vivo","volume":"149","author":"Dunkley","year":"2019","journal-title":"J.\u00a0Neurochem."},{"issue":"7","key":"10.1016\/j.biochi.2020.12.002_bib5","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/humu.22565","article-title":"Functional studies of tyrosine hydroxylase missense variants reveal distinct patterns of molecular defects in Dopa-responsive dystonia","volume":"35","author":"Fossbakk","year":"2014","journal-title":"Hum. Mutat."},{"issue":"Pt 6","key":"10.1016\/j.biochi.2020.12.002_bib6","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/brain\/awq087","article-title":"Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis","volume":"133","author":"Willemsen","year":"2010","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/j.biochi.2020.12.002_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0006-8993(00)02758-X","article-title":"The 4F2hc\/LAT1 complex transports L-DOPA across the blood-brain barrier","volume":"879","author":"Kageyama","year":"2000","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.biochi.2020.12.002_bib8","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/mds.25382","article-title":"Levodopa-induced dyskinesias in tyrosine hydroxylase deficiency","volume":"28","author":"Pons","year":"2013","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.biochi.2020.12.002_bib9","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbapap.2015.04.030","article-title":"Discovery of compounds that protect tyrosine hydroxylase activity through different mechanisms","volume":"1854","author":"Hole","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.biochi.2020.12.002_bib10","doi-asserted-by":"crossref","first-page":"8336","DOI":"10.1038\/s41598-019-44803-1","article-title":"Targeted repositioning identifies drugs that increase fibroblast growth factor 20 production and protect against 6-hydroxydopamine-induced nigral cell loss in rats","volume":"9","author":"Fletcher","year":"2019","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.biochi.2020.12.002_bib11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/aje\/kwaa012","article-title":"Beta 2-agonists and the incidence of Parkinson disease","volume":"189","author":"Giorgianni","year":"2020","journal-title":"Am. J. Epidemiol."},{"issue":"9","key":"10.1016\/j.biochi.2020.12.002_bib12","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/mds.108","article-title":"beta2-adrenoceptor agonists and antagonists and risk of Parkinson\u2019s disease","volume":"33","author":"Gronich","year":"2018","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.biochi.2020.12.002_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1474-4422(19)30400-4","article-title":"beta-adrenoreceptors and the risk of Parkinson\u2019s disease","volume":"19","author":"Hopfner","year":"2020","journal-title":"Lancet Neurol."},{"issue":"6354","key":"10.1016\/j.biochi.2020.12.002_bib14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1126\/science.aaf3934","article-title":"beta2-Adrenoreceptor is a regulator of the alpha-synuclein gene driving risk of Parkinson\u2019s disease","volume":"357","author":"Mittal","year":"2017","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.biochi.2020.12.002_bib15","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1021\/acschemneuro.0c00154","article-title":"Circular dichroism spectroscopy identifies the beta-adrenoceptor agonist salbutamol as a direct inhibitor of Tau filament formation in\u00a0vitro","volume":"11","author":"Townsend","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biochi.2020.12.002_bib16","doi-asserted-by":"crossref","first-page":"30390","DOI":"10.1038\/srep30390","article-title":"Stable preparations of tyrosine hydroxylase provide the solution structure of the full-length enzyme","volume":"6","author":"Bezem","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.biochi.2020.12.002_bib17","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/nprot.2007.321","article-title":"The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability","volume":"2","author":"Niesen","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biochi.2020.12.002_bib18","series-title":"Protein Homeostasis Diseases","first-page":"329","article-title":"Chapter 15 - differential scanning fluorimetry in the screening and validation of pharmacological chaperones for soluble and membrane proteins","author":"St\u00f8ve","year":"2020"},{"issue":"1","key":"10.1016\/j.biochi.2020.12.002_bib19","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1038\/s41598-018-37072-x","article-title":"Isothermal analysis of ThermoFluor data can readily provide quantitative binding affinities","volume":"9","author":"Bai","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biochi.2020.12.002_bib20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0021-9673(00)80522-1","article-title":"Rapid and sensitive assay of tyrosine 3-monooxygenase activity by high-performance liquid chromatography using the native fluorescence of DOPA","volume":"198","author":"Haavik","year":"1980","journal-title":"J.\u00a0Chromatogr."},{"issue":"33","key":"10.1016\/j.biochi.2020.12.002_bib21","doi-asserted-by":"crossref","first-page":"19737","DOI":"10.1074\/jbc.271.33.19737","article-title":"Conformational properties and stability of tyrosine hydroxylase studied by infrared spectroscopy. Effect of iron\/catecholamine binding and phosphorylation","volume":"271","author":"Martinez","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2020.12.002_bib22","doi-asserted-by":"crossref","first-page":"39488","DOI":"10.1038\/srep39488","article-title":"Tyrosine hydroxylase binding to phospholipid membranes prompts its amyloid aggregation and compromises bilayer integrity","volume":"6","author":"Baumann","year":"2016","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.biochi.2020.12.002_bib23","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1021\/bi00016a022","article-title":"Resonance Raman studies of catecholate and phenolate complexes of recombinant human tyrosine hydroxylase","volume":"34","author":"Michaud-Soret","year":"1995","journal-title":"Biochemistry"},{"issue":"45","key":"10.1016\/j.biochi.2020.12.002_bib24","doi-asserted-by":"crossref","first-page":"15638","DOI":"10.1021\/bi9815290","article-title":"Crystallographic analysis of the human phenylalanine hydroxylase catalytic domain with bound catechol inhibitors at 2.0 A resolution","volume":"37","author":"Erlandsen","year":"1998","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.biochi.2020.12.002_bib25","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s40273-018-0668-8","article-title":"Cost effectiveness of pharmacological treatments for asthma: a systematic review","volume":"36","author":"Rodriguez-Martinez","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"5691","key":"10.1016\/j.biochi.2020.12.002_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/277032a0","article-title":"Mechanism of beta-adrenergic relaxation of smooth muscle","volume":"277","author":"Scheid","year":"1979","journal-title":"Nature"},{"issue":"2-3","key":"10.1016\/j.biochi.2020.12.002_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1569-9048(03)00146-0","article-title":"Regulation of beta-adrenergic responses in airway smooth muscle","volume":"137","author":"Shore","year":"2003","journal-title":"Respir. Physiol. Neurobiol"},{"issue":"4","key":"10.1016\/j.biochi.2020.12.002_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00002826-200307000-00011","article-title":"Albuterol improves response to levodopa and increases skeletal muscle mass in patients with fluctuating Parkinson disease","volume":"26","author":"Uc","year":"2003","journal-title":"Clin Neuropharmacol"},{"issue":"8","key":"10.1016\/j.biochi.2020.12.002_bib29","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1212\/WNL.44.8.1511","article-title":"Beta 2-adrenergic agonist as adjunct therapy to levodopa in Parkinson\u2019s disease","volume":"44","author":"Alexander","year":"1994","journal-title":"Neurology"},{"issue":"8797","key":"10.1016\/j.biochi.2020.12.002_bib30","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0140-6736(92)90313-R","article-title":"\u201cWearing-off\u201d and beta 2-adrenoceptor agonist in Parkinson\u2019s disease","volume":"339","author":"Hishida","year":"1992","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biochi.2020.12.002_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11481-018-09831-0","article-title":"Beta2-Adrenoceptor agonists in Parkinson\u2019s disease and other synucleinopathies","volume":"15","author":"Magistrelli","year":"2020","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"issue":"2","key":"10.1016\/j.biochi.2020.12.002_bib32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.biochi.2020.12.002_bib33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/187152712800792785","article-title":"A\u00a0synopsis on the role of tyrosine hydroxylase in Parkinson\u2019s disease","volume":"11","author":"Tabrez","year":"2012","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"issue":"1","key":"10.1016\/j.biochi.2020.12.002_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbrc.2005.07.183","article-title":"Regulatory mechanism of tyrosine hydroxylase activity","volume":"338","author":"Fujisawa","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biochi.2020.12.002_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1471-4159.1991.tb02098.x","article-title":"Conversion of tyrosine hydroxylase to stable and inactive form by the end products","volume":"57","author":"Okuno","year":"1991","journal-title":"J.\u00a0Neurochem."},{"issue":"Pt 10","key":"10.1016\/j.biochi.2020.12.002_bib36","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1093\/brain\/awv224","article-title":"Brain catecholamine depletion and motor impairment in a Th knock-in mouse with type B tyrosine hydroxylase deficiency","volume":"138","author":"Korner","year":"2015","journal-title":"Brain"}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908420303229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908420303229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:33:39Z","timestamp":1778506419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908420303229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":36,"alternative-id":["S0300908420303229"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2020.12.002","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levalbuterol lowers the feedback inhibition by dopamine and delays misfolding and aggregation in tyrosine hydroxylase","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2020.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights reserved.","name":"copyright","label":"Copyright"}]}}